Burning Rock and IMPACT Therapeutics Announce a Global Strategic Partnership for Companion Diagnostics Development Read more
FDA grants Priority Review to Roche’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer Read more
DisperSol and Catalent Collaborate to Establish KinetiSol Technology Manufacturing Hub for DisperSol Pharmaceutical Pipeline Read more
Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma Read more
Ipsen and Exicure enter into exclusive collaboration targeting rare neurodegenerative disorders Read more
The latest innovations in digital health and on-body drug delivery for the pharmaceutical industry Read more
Celltrion Healthcare announces acceptance and priority review by Health Canada of New Drug Submission for its monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) Read more
GC Pharma and Tottori University Enter Research Collaboration and License Agreement for Development of GM1 Gangliosidosis Chaperone Therapy Read more